Effects of non-covalent self-association on the subcutaneous absorption of a therapeutic peptide

Pharmaceutical Research

Volumn 15, Issue 2, 1998, Pages 254-262

  Clodfelter, Dean K ^a   Pekar, Allen H ^a   Rebhun, Dawn M ^a   Destrampe, Kevin A ^a   Havel, Henry A ^a   Myers, Sharon R ^a   Brader, Mark L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Aggregation; Glucagon like peptide 1; Peptide; Subcutaneous absorption

Indexed keywords

AMINO ACID DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; GEL PERMEATION CHROMATOGRAPHY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; DOGS; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; INJECTIONS, SUBCUTANEOUS; INSULIN; LIGHT; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; SCATTERING, RADIATION; SPECTROPHOTOMETRY, INFRARED;

EID: 0031918487     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011918719017     Document Type: Article

References (35)

1. J. L. Cleland and R. Langer in Formulation and Delivery of Proteins and Peptides, American Chemical Society, Washington, D.C., 1994, pp 1-19.
2. M. C. Manning, J. E. Matsuura, B. S. Kendrick, J. D. Meyer, J. J. Dormish, M. Vrkljan, J. R. Ruth, J. F. Carpenter, and E. Shefter. Biotech. Bioeng. 48:506-512 (1995).
3. B. Chen, T. Arakawa, C. F. Morris, W. C. Kenny, C. M. Wells, and C. G. Pitt. Pharm. Res. 11:1581-1587 (1994).
4. D. N. Brems. Folding of bovine growth hormone, in Protein Folding: Deciphering the Second Half of the Genetic Code (eds. L. M. Gierash and J. King) 129-135, Washington, D. C., 1990).
5. J. London, C. Skrzynia, and M. E. Goldberg. Eur. J. Biochem. 47:409-415 (1974).
6. M. Gutniak, C. Orskov, J. J. Ahren, and B. Efendic. N. Engl. J. Med. (1992).
7. M. K. Gutniak, B. Linde, J. J. Holst, and S. Efendic. Diabetes Care 17:1039-1044 (1994).
8. M. Nauck. Diabetic Medicine 13:39-43 (1996).
9. P. J. Casey. Science 268:221-225 (1995).
10. D. Clodfelter, J. Reilly, and M. Nussbaum submitted for publication.
11. S. W. Provencher and J. Glockner. Biochemistry 20:33-37 (1981).
12. S. W. Provencher. CONTIN Users Manual. EMBL Technical Report DA05, European Molecular Biology Laboratory, Heidelberg, (1982).
13. H. K. Schachman. Utracentrifugation, Diffusion, and Viscometry, Academic Press, New York (1957).
14. D. K. McRorie and P. J. Voelker. Self-Associating Systems in the Analytical Ultracentrifuge, Beckman Instruments (1993).
15. H. Qi and D. L. Heller. J. Pharm. Sci. Tech. 49:289-293 (1995).
16. Y. Kim and C. A. Rose. Pharm. Res. 12:1284-1288 (1995).
17. W. W. Yau, J. J. Kirkland, and D. D. Bly in Modern Size Exclusion Chromatography. Wiley, New York (1979).
18. A. Dong, S. J. Prestrelski, S. D. Allison, and J. F. Carpenter. J. Pharm. Sci. 84:415-424 (1995).
19. Y. Takakura, M. Hashida, and H. Sezaki. Lymphatic transport after parenteral drug administration. In W. N. Charman and V. J. Stella (eds.) Lymphatic Transport of Drugs CRC Press, Boca Raton (1992) 255-277.
20. W. Parker and P.-S. Song. Biophys. J. 61:1435-1439 (1992).
21. J. Johansson, G. Nilsson, R. Stromberg, B. Robertson, H. Jornvall, and T. Curstedt. Biochem. J. 307:535-541 (1995).
22. M. M. E. Snel, R. Kapstein, and B. Kruijff. Biochemistry 33:3387 (1991).
23. C. Tanford. The Hydrophobic Effect, John Wiley and Sons, New York (1980) 139-145.
24. K. Thornton and D. G. Gorenstein. Biochemistry 33:3532-3539 (1994).
25. W. Yonemoto, M. L. McGlone, and S. S. Taylor. J. Biol. Chem. 268:2348-2352 (1993).
26. K. W. Traxler and T. G. Dewey. Biochemistry 33:1718-1723 (1994).
27. M. Joseph and R. Nagaraj. J. Biol. Chem 19439-19445 (1995).
28. G. James and E. N. Olson. Biochemistry 29:2623-2634 (1990).
29. J. Zuidema, F. Kadir, H. A. C. Titulaer, and C. Oussoren. Int. J. Pharmaceutics 105:189-207 (1994).
30. H. R. Constantino, R. Langer, and A. M. Klubanov. J. Pharm. Sci. 83:1662-1669 (1994).
31. J. Heller. Use of Poly(ortho esters) and polyanhydrides in the development of peptide and protein delivery systems. In J. L. Cleland, and R. Langer (eds.) Formulation and Delivery of Proteins and Peptides, American Chemical Society, Washington DC (1994) 292-305.
32. Z. Gao, A. J. Shukla, J. R. Johnson, and W. R. Crowley. Pharm. Res. 12:857-863 (1995).
33. J. Brange, U. Ribel, J. F. Hansen, G. Dodson, M. T. Hansen, S. Havelund, S. G. Melberg, F. Norris, K. Norris, L. Snel, A. R. Sorensen, and H. O. Voigt. Nature 333:679-682 (1988).
34. J. Brange, D. R. Owens, S. Kang, and A. Volund. Diabetes Care 13:923-954 (1990).
35. D. L. Bakaysa, J. Radziuk, H. A. Havel, M. L. Brader, S. Li, S. W. Dodd, J. M. Beals, A. H. Pekar, and D. N. Brems. Protein Science 5:2521-2531 (1996).